Multigene panel provides efficient ataxia diagnosis
Answers from the Lab
Hereditary ataxia is complex, with significant clinical overlap among multiple subtypes. In this test-specific episode of the "Answers From the Lab" podcast, Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC, explain how Mayo Clinic Laboratories' ATAXP panel provides cost-effective molecular diagnosis to guide management of this movement disorder.
"This panel uses next-generation sequencing to detect variants in 198 genes, which have been carefully vetted by experts," Lauer says. "Ensuring that the genes on a large testing panel are truly associated with disease assists in minimizing detection of variants of uncertain significance."
The panel can be especially helpful if an individual's clinical and family history isn't consistent with spinocerebellar ataxia or Friedreich ataxia. Mayo Clinic Laboratories also offers testing that targets those forms of ataxia.
"Understanding the underlying cause of an individual's genetic condition can help with prognosis, clinical management and family screening," Pickart says. "Once nongenetic etiologies have been excluded, it is reasonable to consider genetic testing for any individual to assess for hereditary ataxia."
Listen to learn more about Mayo Clinic Laboratories' hereditary ataxia panel.
Note: Podcasts will not play back on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.
Establishing a molecular diagnosis for patients with ataxia.
Identifying variants within genes known to be associated with ataxia, allowing for predictive testing of at-risk family members.
Patient Preparation: A previous bone marrow transplant from an allogenic donor will interfere with testing. Call 800-533-1710 for instructions for testing patients who have received a bone marrow transplant.
Specimen Type: Whole blood
Container/Tube: Lavender top (EDTA) or yellow top (ACD)
Acceptable: Any anticoagulant
Specimen Volume: 3 mL
Specimen Stability Information: Ambient (preferred)/Refrigerated
Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune liver disease.
David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler test ordering.
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal health.